This report from pharmaceutical research firm Best Practices, LLC, notes that the landscape of scientific publications strategy, planning and delivery is changing with the advent of transparency guidelines. It further states that half of global publications groups are fully located in the marketing function, but publications leaders forecast a shift to medical groups to increase clinical presentation. The study included companies such as Pfizer, GlaxoSmithKline, Lilly and Merck.
Category: White Papers
Click here